CG Oncology’s main asset is cretostimogene, an oncolytic virus in late-stage development as a treatment for advanced bladder cancer. The IPO filing follows the report of interim efficacy data showing a 75% complete response rate.
With the additional $1.72 million in grants for further development of its stroke rehab technology, the Irvine, California-based company's funding now totals more than $8 million.
Boston Scientific may have purchased Swiss structural heart company Symetis for many reasons but one could very well be that the Lotus aortic valve is not ready for prime time.
Edwards Lifesciences is paying up to $690 million to a buy an Israeli company that makes transcatheter mitral valve and tricuspid repair devices. Last year it bought a mitral valve replacement company for about $400 million.
The public company based in the U.K. has struggled to gain a foothold in the U.S. market and has eliminated its sales force and moved commercial operations to Europe.
The Food and Drug Administration expands the indication for Edwards Lifesciences' Sapien 3 valve allowing the transcatheter aortic valve replacement procedure to aortic stenosis patients who have intermediate risk of undergoing open-heart surgery.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The newly formed Providence St. Joseph Health comprises 50 hospitals, 829 clinics and affiliated social services in seven states, making it the third-largest nonprofit healthcare organization in the country.
TherOx has had a withdrawn IPO, snub from the FDA, but looks like it's rebounding with its promising device that could help salvage damaged heart tissue after a heart attack.
Transcatheter aortic valve implantation is a promising next-gen technology for common conditions like aortic stenosis. Irvine-based JenaValve Technology just added another $26.5 million to its Series C round, bringing the devicemaker to nearly $100 million for the round for its TAVI prosthetic valve.
An FDA-cleared surgical prosthesis that treats hernias has attracted some recent capital, ostensibly so the company – called Insightra Medical – can expand its scope abroad. The Irvine, California-based company just raised $6.1 million, according to a regulatory filing. This is right on the heels of a $6 million financing round, filed in May. Insightra […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A California startup developing transcatheter mitral valve implantation technology to repair leaking heart valves has raised $32.5 million, according to a regulatory filing. CardiAQ Valve Technologies, based in Irvine, aims to market the technology, once approved, as an alternative to open heart surgery to fix the problem of mitral valve regurgitation. An outside spokesman […]
Losing the Ryder Cup this year to the Europeans was every bit unexpected. Almost as unexpected as Edwards Lifesciences suddenly pre-announcing late Monday that it would miss its 3rd quarter revenue forecasts largely because of poor sales growth for U.S. transcatheter aortic valve replacement procedures. Third quarter U.S. TAVI sales of $55 million were off […]
Interventional Spine, that has developed spinal implants that can be delivered percutaneously, raised $1.6 million by issuing debt. Here are the details: Industry: Medical devices Location: Irvine, California Solution/Product: The company makes several products for U.S. and overseas markets. Its most recent product is the FDA cleared PerX360° system that makes it possible to have a […]
A California startup is transforming the familiar computer mouse into a health monitor by inserting devices like blood pressure monitors and blood glucose monitors in it. CalHealth Inc., based in Irvine, is getting ready to launch the MD Mouse by the end of the year. The product will be able to measure blood pressure by […]
IPads are used in roughly one quarter of U.S. medical schools, free of charge or as a mandatory tool for learning. University of California at Irvine School of Medicine began using them in 2010. As these classes progress, it and other medical schools have found that the use of iPads is having some unintended consequences, […]
